Fresenius Medical (FMS) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts FMS Hot Sheet
Join SI Premium – FREE
Fresenius Medical Care Ag & Co. Kgaa (NYSE: FMS) reported Q2 EPS of $0.96, $0.04 better than the analyst estimate of $0.92. Revenue for the quarter came in at $4.42 billion versus the consensus estimate of $4.54 billion.
For earnings history and earnings-related data on Fresenius Medical Care Ag & Co. Kgaa (FMS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CAI International (CAI) Misses Q3 EPS by 11c ; Offers Guidance
- Host Hotels & Resorts (HST) Tops Q3 EPS by 1c; offers guidance
- biote Corp. (BTMD) Misses Q3 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
